IRADIMED CORPORATION Operating Lease, Payments
IRADIMED CORPORATION (IRMD) reported Operating Lease, Payments of $161.81 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2023-05-04
- IRADIMED CORPORATION operating lease, payments for the quarter ending 2023-03-31 was $161.81K, a 26.34% increase year-over-year.
- IRADIMED CORPORATION operating lease, payments for the quarter ending 2022-12-31 was $169.64K, a 35.11% increase year-over-year.
- IRADIMED CORPORATION operating lease, payments for the quarter ending 2022-09-30 was $107.71K, a 14.22% decline year-over-year.
- IRADIMED CORPORATION operating lease, payments for the quarter ending 2022-06-30 was $129.03K, a 6.71% increase year-over-year.
- IRADIMED CORPORATION operating lease, payments for fiscal 2022 was $534.47K, a 9.05% increase from fiscal 2021.
- IRADIMED CORPORATION operating lease, payments for fiscal 2021 was $490.11K, a 14.01% increase from fiscal 2020.
- IRADIMED CORPORATION operating lease, payments for fiscal 2020 was $429.89K, a 0.40% increase from fiscal 2019.
- IRADIMED CORPORATION operating lease, payments for fiscal 2019 was $428.18K, a 2.25% increase from fiscal 2018.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2023-03-31 | $161.81K 10-Q · filed 2023-05-04 | $331.46K derived: sum of 2 quarters · filed 2023-05-04 | $439.17K derived: sum of 3 quarters · filed 2023-05-04 | $568.20K derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | $169.64K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $277.35K derived: sum of 2 quarters · filed 2023-03-02 | $406.39K derived: sum of 3 quarters · filed 2023-03-02 | $534.47K 10-K · filed 2023-03-02 |
| 2022-09-30 | $107.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $236.74K derived: sum of 2 quarters · filed 2022-11-03 | $364.82K 10-Q · filed 2022-11-03 | $490.39K derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-06-30 | $129.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $257.12K 10-Q · filed 2022-08-05 | $382.68K derived: sum of 3 quarters · filed 2023-05-04 | $508.24K derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-03-31 | $128.08K 10-Q · filed 2023-05-04 | $253.65K derived: sum of 2 quarters · filed 2023-05-04 | $379.21K derived: sum of 3 quarters · filed 2023-05-04 | $500.12K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $125.56K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $251.13K derived: sum of 2 quarters · filed 2023-03-02 | $372.04K derived: sum of 3 quarters · filed 2023-03-02 | $490.11K 10-K · filed 2023-03-02 |
| 2021-09-30 | $125.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $246.48K derived: sum of 2 quarters · filed 2022-11-03 | $364.55K 10-Q · filed 2022-11-03 | $472.58K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $120.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $238.98K 10-Q · filed 2022-08-05 | $347.01K derived: sum of 3 quarters · filed 2022-08-05 | $453.99K derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $118.07K 10-Q · filed 2022-05-06 | $226.10K derived: sum of 2 quarters · filed 2022-05-06 | $333.08K derived: sum of 3 quarters · filed 2022-05-06 | $440.87K derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $108.03K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $215.01K derived: sum of 2 quarters · filed 2022-03-04 | $322.81K derived: sum of 3 quarters · filed 2022-03-04 | $429.89K 10-K · filed 2022-03-04 |
| 2020-09-30 | $106.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $214.78K derived: sum of 2 quarters · filed 2021-11-05 | $321.86K 10-Q · filed 2021-11-05 | $429.13K derived: sum of 4 quarters · filed 2022-03-04 |
| 2020-06-30 | $107.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $214.88K 10-Q · filed 2021-08-06 | $322.15K derived: sum of 3 quarters · filed 2022-03-04 | $429.72K derived: sum of 4 quarters · filed 2022-03-04 |
| 2020-03-31 | $107.08K 10-Q · filed 2021-05-07 | $214.35K derived: sum of 2 quarters · filed 2022-03-04 | $321.92K derived: sum of 3 quarters · filed 2022-03-04 | $428.60K derived: sum of 4 quarters · filed 2022-03-04 |
| 2019-12-31 | $107.27K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $214.84K derived: sum of 2 quarters · filed 2022-03-04 | $321.52K derived: sum of 3 quarters · filed 2022-03-04 | $428.18K 10-K · filed 2022-03-04 |
| 2019-09-30 | $107.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $214.25K derived: sum of 2 quarters · filed 2020-11-06 | $320.91K 10-Q · filed 2020-11-06 | $384.55K derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-06-30 | $106.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $213.34K 10-Q · filed 2020-08-06 | $276.98K derived: sum of 3 quarters · filed 2021-03-05 | $426.66K derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-03-31 | $106.66K 10-Q · filed 2020-05-07 | $170.31K derived: sum of 2 quarters · filed 2021-03-05 | $319.98K derived: sum of 3 quarters · filed 2021-03-05 | $423.93K derived: sum of 4 quarters · filed 2021-03-05 |
| 2018-12-31 | $63.65K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $213.32K derived: sum of 2 quarters · filed 2021-03-05 | $317.27K derived: sum of 3 quarters · filed 2021-03-05 | $418.77K 10-K · filed 2021-03-05 |
| 2018-09-30 | $149.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $253.62K derived: sum of 2 quarters · filed 2019-11-07 | $355.13K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $103.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $205.45K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $101.50K 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $409.38K 10-K · filed 2020-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |